'Moderate dose' diaporamas de présentation

FDA Advisory Committee May 15, 2003

FDA Advisory Committee May 15, 2003. Genentech Marketing Application STN 103976 / 0 Omalizumab Recombinant human anti-IgE for treatment of asthma Efficacy Review. Omalizumab: Proposed indication. Proposed indication:

769 views • 45 slides

EARLY NONSTOCHASTIC EFFECTS/LATE STOCHASTIC EFFECTS

EARLY NONSTOCHASTIC EFFECTS/LATE STOCHASTIC EFFECTS. Sherer Chapter 7 and 8 Reference: Bushong , Chapter 36 and 37 . Review of Dose response curves. Threshold Non threshold Linear quadratic non threshold curve Non linear (s-shaped or sigmoid) . Early, Nonstochastic Effects:.

699 views • 38 slides

Management of Inpatient Hyperglycemia in Special Populations

Management of Inpatient Hyperglycemia in Special Populations. Overview. Inpatient Hyperglycemia and Poor Outcomes in Numerous Settings.

606 views • 36 slides

Statins and the Liver

Statins and the Liver. Dr Udaya Kalubowila MBBS, MD Senior Registrar in Gastroenterology/ Medicine University Medical Unit CNTH Ragama . Introduction. Cardiovascular disease are the leading cause of death in many countries.

878 views • 28 slides

282 views • 17 slides